01 penicillins and cephalosporins
Penicillin products run smoothly as a whole.
Amoxicillin, amoxicillin sodium. Amoxicillin, the market was stable in the fourth week of April; Amoxicillin sodium, with a market price of 300-340, showed a weak trend in April.
Amoxicillin and clavulanate potassium operated weakly. The market price was 485, with a month on month decrease of 0.9% and a year-on-year decrease of 34.1%. The market was at a low point in the same period in recent five years. The downward trend in April was obvious.
Ampicillin, ampicillin sodium. Ampicillin is weak; Ampicillin sodium 280-325 showed a downward trend in April.
Penicillin sodium, with a weak operation, has a market price of 109-119/ billion, a month on month decrease of 0.4%, a decrease of 0.3% and a year-on-year decrease of 28.7%, hovering at a low level in the past five months.
Penicillin potassium industrial salt operated weakly, with a transaction price of 59-69/ billion, a month on month decrease of 0.7% and a year-on-year decrease of 37.1%, reaching a new low in nearly six months.
Ceftiofur sodium, ceftiofur hydrochloride, cefquinome sulfate. Ceftiofur sodium, running smoothly, with a market price of 840; Ceftiofur hydrochloride, with a stable market price of 770-860; Cefquinome sulfate operated weakly. The market price was 3920, with a month on month decrease of 0.4% and a year-on-year decrease of 18.9%. The average price of the same period in 2025-2021 was 4860, 5520, 6158, 6900 and 8350 respectively.
.
02 chloramphenicol and tetracyclines
Tetracycline products generally operate weakly.
Florfenicol operates weakly, with large differences in transaction prices among regions and brands, and the market price is below 170. After the market adjustment in March, the trading market cooled down in April of the second quarter.
Thiamphenicol operated smoothly. The market price was 177, with a month on month increase of 0.9% and a year-on-year decrease of 11.5%. The average price of the same period in 2025-2023 was 198, 235 and 303 respectively. The market trend was stable in April.
Doxycycline hydrochloride operated weakly and fell back from the market last week.
Oxytetracycline, oxytetracycline hydrochloride. Oxytetracycline, weak operation; .
Chlortetracycline Hydrochloride, with a market price of 155, increased slightly compared with last week, with a year-on-year decrease of more than 10%.
For chloramphenicol products in the first quarter, the market of florfenicol was stable from January to March, with average prices of 169, 160 and 164 respectively. The market rebounded slightly at the end of February and early March, and the price range in March was 159-169; The average price of thiamphenicol in the first quarter was 169.
03 aminoglycosides
The overall market of aminoglycoside products fell.
Neomycin sulfate, the overall market is stable, the market price is 145-155/ billion, and the market trend is stable in April.
Hydrochloric acid (sulfuric acid) spectinomycin has a stronger operation and a narrower increase. The market price is 540-565, and the average price from 25 to April 2023 is 570, 495, and 513 respectively.
.
Apramycin sulfate, the market is stable, with little change from last week.
Kanamycin monosulfate, the market transaction price was 295/ billion, with a month on month decrease of 1.3%. The transaction price was flat year on year, and the market trend was stronger in April.
Amikacin sulfate, with a market price of 730, showed a stable trend in April.
Gentamicin sulfate has a stable market.
In the first quarter, aminoglycoside products showed a stable overall trend. Neomycin sulfate showed a trend of "stable start - narrow stability - small decline". From January to February, the price mainly fluctuated in the narrow range of 153-155/ billion. In March, the price range moved down to 145-155/ billion, and the year-on-year decline expanded from 3% to 6%. The market as a whole was in the stage of destocking, and downward pressure continued to exist, but the fluctuation range in the quarter was not large. In the middle and late March, the heat increased and transactions were active; The transaction price of spectinomycin hydrochloride ranged from 535 to 555, with an increase of more than 3%; Streptomycin sulfate 265-310; The average prices of Apramycin sulfate and kanamycin sulfate monosulfate were 191 and 294, respectively.
04 macrolides and other antibiotics
The overall market of macrolides is stable.
Tylosin tartrate is highly popular and actively traded. The market price is about 270. The average prices from April to June in the second quarter of last year were 272, 287 and 280 respectively, and the average prices in the third and fourth quarters were 285 and 292 respectively.
Tilmicosin, tilmicosin phosphate. Tilmicosin, the market price is about 360; The market price of tilmicosin phosphate is about 300, which is basically unchanged from last week, with a year-on-year decrease of 6.5%. The average price from April to June in the second quarter of last year was 306, 336 and 425 respectively.
.
Tyvancomycin tartrate, with a trading market price of 370-390, has shown a steady decline in the recent four weeks, with a year-on-year decrease of 3.9%.
Telamycin, with a market price of 5950, showed a stable trend in April.
Erythromycin thiocyanate, with a stable market price of about 480, showed a stable trend in April.
Colistin sulfate is relatively strong, and the market price is around 115.
Tamoxifen fumarate has a stable market.
Lincomycin hydrochloride continued to drop slightly this week. The market price was 305-339/ billion, with a month on month decrease of 0.5% and a year-on-year decrease of 19.2%. At the same time, it also confirmed that the market supply this year was better than that of last year. The average prices from January to march in the first quarter of last year were 443, 439 and 420 respectively; The average price from January to march in 2024 is 298, 305 and 299 respectively.
. Tilmicosin started to rise vigorously in the second week of March in the first quarter, and the highest market price rose to more than 350. The gradual correction was made at the end of March, and the average prices from January to March were 364, 350 and 345 respectively; Erythromycin thiocyanate, with an average price of 481 in the first quarter, was less affected by geopolitics, and the average transaction price was lower than that of the same period last year.
Lincomycin hydrochloride, a lincosamide antibiotic, declined mainly in the first quarter, with a decrease of 3.2%. The average prices from January to March were 331, 321, 329, 225, 443, 439, 420, 2024, 298, 305, 299, 2026, respectively. The first quarter market is close to 2024.
Original articles of Asia Pacific Yihe data analysis Institute are prohibited from being reproduced without permission. Infringement must be prosecuted. Please contact the author for reprinting and quoting, indicating the original source.
05 quinolones
Quinolone products shock adjustment.
Enrofloxacin, enrofloxacin hydrochloride. .
Ciprofloxacin lactate (hydrochloric acid) has a price of 165. The overall market is stable, with a year-on-year decrease of 11.3% compared with last week. The average price from 2025 to April 2023 is 186, 196 and 234 respectively.
Sarafloxacin Hydrochloride has a stable market.
The market price of marbofloxacin was 2220, with a month on month decrease of 1.0% and a year-on-year decrease of 16.2%.
06 sulfonamides
The market demand for sulfonamide products is weak and the market is weak.
Sulfamonomethoxine (sodium), the market runs smoothly.
Sulfamethoxine (sodium) has a stable market price of 230-245.
Sulfamethoxazole (sodium), market price 100-145.
Sulfadiazine (sodium) has a stable market. The market price is 155. The average price of the same period from 2025 to 2023 is 165, 161 and 201 respectively.
The market price of sulfamethazine (sodium) is 99-109, which is stable compared with last week, with a year-on-year increase of 24.4%.
The price of Sulfaquinoxaline sodium was basically unchanged from last week, with a year-on-year increase of more than 20%. The average price from 2025 to April 2023 was 174, 169 and 295 respectively.
The price of sulfachlorpyrazine sodium is basically unchanged from last week, and the average price from 2025 to April 2023 is 215, 228 and 300 respectively.
The price of sulfaclodazine sodium was basically unchanged from last week, and the average price from 2025 to April 2023 was 171, 140 and 180 respectively.
Trimethoprim has a stable market price of 400.
Trimethoprim, trimethoprim lactate. Trimethoprim, market price 245; Trimethoprim lactate, with a market price of 190, showed a downward trend in April.
07 antiparasitic
Antiparasitic products run smoothly as a whole.
Albendazole, with high popularity, rose in the market and narrowed the increase. The market price was about 160, with a month on month increase of 1.8%, which was flat compared with the same period last year. The transaction prices of different regions and brands varied greatly. In the first quarter, the market opened low and went high. It hit the bottom at the end of January and remained low until February. It rose in mid March and entered the fast lane. In the second quarter, the market was stable and had an upward trend.
Fenbendazole was more stable than last week.
Abamectin was actively traded and the market continued to rise. The trading price was around 630, and the market trended upward in April.
.
Dikezhuli, with a market price of 1050, rose by 3.0% year-on-year over last week.
Torquin Zhuli, strong operation, market price 860.
Levamisole hydrochloride, slightly lower than the market last week.
Aminopropyl hydrochloride, the market is stable.
Metronidazole has a stable market, and its price is basically flat compared with last week. The average price of metronidazole in the same period from 2025 to 2023 is 79, 78 and 85 respectively. The market in April has an upward trend.
The price of dimenidazole was basically unchanged from last week, and the average price of the same period from 2025 to 2023 was 89, 99 and 147 respectively.
Praziquantel was slightly lower than that of last week.
.
Copyright of the original article of Asia Pacific Yihe data analysis Institute. The market data analysis is the comprehensive price of bulk products.
08 antipyretic analgesic, antiasthmatic and immune enhancing products
The overall trend of antipyretic and analgesic products is stable.
The market price range of flunixin meglumine is 360-380, with a month on month decrease of 1.5% and a year-on-year decrease of more than 10%. The market showed a downward trend in April.
Analgin, the trading market is stable, and the transaction price in the first quarter of last year was above 400 lines.
Acetaminophen, the market fell down.
Aminopyrine, with a market price of 100, was stable compared with last week, with a year-on-year decrease of 2.9%.
Aminophylline has a stable market price of 107.
Aspirin, the market price is 20000/ ton.
Taurine, the downward trend of the market.
After strong market growth in March, cabazirin calcium entered April, and some brands fell back to less than 30. The transaction price in the trading market continued to decline this week, with an increase of more than 10% in the first quarter.
09 veterinary drug excipients and other categories
Acetylmequine, market shock callback.
Sodium camphorsulfonate continued to rise.
Chlorpheniramine showed a downward trend. In the first quarter, it rose violently in early March, and the market fell significantly in April.
.
The supply of citric acid eased, and the market continued to rise, with a market price of 4600/ ton.
Sodium citrate is in short supply and the market is rising. The market price is 4690/ ton.
Sodium carbonate, with a stable market price of 2120/ ton.
Sodium bicarbonate, weak operation, market price 2330/ ton.
Glucose, trading price 3850-6400/ ton, rising trend.
Jiayi powder has a trading price of 2680-3260/ ton, and the market tends to be stable.
Soluble starch, strong operation, market price 12600/ ton.
.
For more information, please join the Asia Pacific Yihe data analysis Institute to grasp the market changes in real time.
10 plant raw materials Chinese medicinal materials
The overall trend of plant raw materials and Chinese medicinal materials is stable.
Shuanghuanglian extract, 56-100.
Astragalus polysaccharide extract, 50-100.
Scutellaria extract, 110-150.
Liquorice extract, 60-100.
Honeysuckle extract, 60-100.
Honeysuckle, 55-120.
Coptis chinensis, 240-290.
Astragalus, 9-12.
Scutellaria baicalensis Georgi, 16-25.
Yanhusuo, 55-65.
Tangerine peel, 10-13.
Hawthorn, 4-6.
.
Dried ginger, 16-25.
Safflower, 50-79.
Banlangen, 15-25.
11 vitamins
The market of vitamin products fell significantly in late April.
VA， Mix 110, water solubility 130, the market fell.
VB1， The market is stable, nitric acid 240, hydrochloric acid 290.
VB2， 98% price 278, 80% price 76.
VB6， The market is stable, and the market price is 115.
VB12 1% ， The market price is 100, and the market is stable.
VC， The market quotation is about 21 feed grade and 30 pharmaceutical grade, and the market is stable.
VD3， The market price is 140 for mixture and 160 for water solubility, and the market tends to slow down.
VE， The mixing material is 100-110, and the water solubility is 120, which is stable but slightly reduced.
VK3， The market price is 90, with a drop in stability.
Calcium pantothenate, market price 79, market decline.
Biotin 2%, market price 39.
Folic acid, the market price is 339, and the market is stable.
